Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

…, K Lechner, JL Nielsen, P Rousselot…

Index: Terada; Takeuchi; Hamada Chemical and Pharmaceutical Bulletin, 1986 , vol. 34, # 5 p. 1917 - 1923

Full Text: HTML

Citation Number: 3109

Abstract

... marrow transplantation a median of 13 months (range, 5 to 22) after randomization: 18 in the imatinib group (1 of whom had crossed over to the combination-therapy group) and 34 in the ... All investigators received grant support from Novartis Pharma for the conduct of the study. ... 5. ...